# Ginger Nausea Pregnancy Guideline: What the Evidence Says
Canonical: https://www.migaku.app/guides/ginger-nausea-pregnancy-guideline-evidence-review
Category: evidence-review
Summary: Ginger Nausea Pregnancy Guideline has 2 source documents in the current Migaku evidence database. The strongest available sources in this first pass are rando
Last reviewed: 2026-05-20
Reviewed by: Migaku Evidence Review
# Ginger Nausea Pregnancy Guideline: What the Evidence Says

## Quick Answer

Ginger Nausea Pregnancy Guideline has 2 source documents in the current Migaku evidence database. The strongest available sources in this first pass are randomized trial, so conclusions should be framed as evidence-aware guidance rather than medical advice.

## Key Takeaways

- This page is generated only from sources stored in the Migaku evidence knowledge base.
- Current evidence mix: 1 randomized trial, 1 preclinical study.
- Claims should be interpreted with the source type, study design, population, and publication date in mind.
- This article is educational and does not replace care from a qualified clinician.

## Evidence Map

| Source | Evidence type | Level | Date | Identifier |
| --- | --- | ---: | --- | --- |
| Ottawa nutritional guide intervention for nausea and vomiting in pregnancy: a randomized controlled trial protocol | randomized trial | 2 | 2025-08-11 | 10.1186/s12978-025-02097-9 |
| Expert-guided approaches to complementary interventions for common side effects of cancer therapies: a practice-based perspective from integrative oncology centers in Baden-W&#252;rttemberg, Germany | preclinical study | 4 | 2025-11-06 | 10.3389/fonc.2025.1667298 |

## What The Sources Report

- Maternal complications associated with severe vomiting during pregnancy can include acute kidney failure, esophageal rupture, coagulation disorders, and in rare instances, Wernicke encephalopathy. [Nazmi Sana (2025); evidence level 2]
- Recent research highlights the potential for NVP to contribute to increased relationship stress, reduced intimacy, and psychological distress for expectant mothers and their partners. [Nazmi Sana (2025); evidence level 2]
- Although advances in oncological therapies have improved survival rates, treatment-related side effects continue to represent a substantial burden for patients. [Winkler Marcela (2025); evidence level 4]
- Inadequate control of CINV can result in malnutrition, dehydration, electrolyte disturbances, treatment delays, and impaired QoL. [Winkler Marcela (2025); evidence level 4]

## How To Read This Evidence

Evidence level 1 generally reflects systematic reviews or meta-analyses. Level 2 includes randomized trials, guidelines, or public-health guidance. Level 3 usually reflects observational or narrative-review evidence. Level 4 is weaker or early-stage evidence. The level is a sorting aid, not a final quality grade.

## Practical Interpretation

There is trial evidence in the current set, but population and intervention details still matter. For ginger nausea pregnancy guideline, the next editorial step is to add more targeted sources and separate strong findings from early or indirect evidence.

## Limits Of This First Pass

This is a small-batch MVP article. It uses the first ingested sources for this topic and should be expanded with more targeted searches, license review, and human editorial checks before being treated as a definitive review.

## References

- Nazmi Sana (2025). Ottawa nutritional guide intervention for nausea and vomiting in pregnancy: a randomized controlled trial protocol. DOI: 10.1186/s12978-025-02097-9. PMCID: PMC12341109. PMID: 40790777. License: https://creativecommons.org/licenses/by-nc-nd/4.0/ http://creativecommons.org/licenses/by-nc-nd/4.0/ This article is .... https://pmc.ncbi.nlm.nih.gov/articles/PMC12341109/
- Winkler Marcela (2025). Expert-guided approaches to complementary interventions for common side effects of cancer therapies: a practice-based perspective from integrative oncology centers in Baden-W&#252;rttemberg, Germany. DOI: 10.3389/fonc.2025.1667298. PMCID: PMC12631479. PMID: 41278285. License: CC BY 4.0. https://pmc.ncbi.nlm.nih.gov/articles/PMC12631479/

## Safety Note

Health information can change, and individual risk depends on medical history, medications, pregnancy status, age, and diagnosis. Talk with a qualified clinician before changing treatment, supplement, or medication routines.